DGX logo

Quest Diagnostics Incorporated Stock Price

NYSE:DGX Community·US$20.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author

DGX Share Price Performance

US$191.25
27.66 (16.91%)
US$197.25
Fair Value
US$191.25
27.66 (16.91%)
3.0% undervalued intrinsic discount
US$197.25
Fair Value
Price US$191.25
AnalystConsensusTarget US$197.25

DGX Community Narratives

AnalystConsensusTarget·
Fair Value US$197.25 3.0% undervalued intrinsic discount

DGX: Core Volume Momentum And New Blood Tests Will Drive Share Momentum

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative

Updated Narratives

DGX logo

DGX: Core Volume Momentum And New Blood Tests Will Drive Share Momentum

Fair Value: US$197.25 3.0% undervalued intrinsic discount
13 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Established dividend payer with acceptable track record.

1 Risk
3 Rewards

Quest Diagnostics Incorporated Key Details

US$10.9b

Revenue

US$7.2b

Cost of Revenue

US$3.6b

Gross Profit

US$2.7b

Other Expenses

US$963.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
8.66
33.45%
8.88%
76.9%
View Full Analysis

About DGX

Founded
1967
Employees
50500
CEO
James Davis
WebsiteView website
www.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Recent DGX News & Updates

Recent updates

No updates